Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

ABSTRACT: Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

PROVIDER: PRJNA270989 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model [microRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here, we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle. 3 Wt, 4 mdx and 4 Pip6e-PMO treated mdx mice

2015-09-24 | E-GEOD-64419 | biostudies-arrayexpress

Multi-level omics analysis of gene expression in a murine model of dystrophin loss and therapeutic restoration [mRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here,we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle. 3 Wt, 4 mdx and 4 Pip6e-PMO treated mdx mice

2015-09-24 | E-GEOD-64418 | biostudies-arrayexpress

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model [microRNA]

2015-09-24 | GSE64419 | GEO

Multi-level omics analysis of gene expression in a murine model of dystrophin loss and therapeutic restoration [mRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here,we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle.

2015-09-24 | GSE64418 | GEO

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-09-24 | E-GEOD-64420 | biostudies-arrayexpress

Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.

Project description: Not available

| S-EPMC4634378 | biostudies-literature

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

Project description:This SuperSeries is composed of the SubSeries listed below.

2015-09-24 | GSE64420 | GEO

Complete phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons

Project description:Duchenne (DMD) muscular dystrophy is an X-linked disease affecting skeletal and cardiac muscle due to deficient dystrophin protein expression. Here we describe the full-length dystrophin restoration by CRISPR/Cas9 in an induced pluripotent stem cell (iPSC) line from a patient carrying a deletion of exons 49-50. Using sinle nuclei-RNA seq we compared the transcriptomic profile of engineered heart tissue (EHTs) derived from original Duchenne iPSC cells and edited iPSC. This analyses allowed us to discriminate the effects of dystrophin restoration in specific cell types present in EHTs.

2026-07-17 | GSE280058 | GEO

Multi-omics Analysis reveals novel therapeutic vulnerabilities in lung cancer

Project description:Multi-omics Analysis reveals novel therapeutic vulnerabilities in lung cancer

| PRJNA670689 | ENA

Therapeutic restoration of mitochondria–endoplasmic reticulum crosstalk for osteoarthritis

Project description:Therapeutic restoration of mitochondria–endoplasmic reticulum crosstalk for osteoarthritis

| PRJNA1306165 | ENA